X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
diagnosis (5) 5
venousthrombosis (5) 5
anticoagulation (4) 4
deep venousthrombosis (4) 4
guidelines (4) 4
humans (4) 4
pulmonary embolism (4) 4
chest pain (3) 3
dyspnoea (3) 3
female (3) 3
heart failure (3) 3
heparin (3) 3
hypotension (3) 3
pregnancy (3) 3
shock (3) 3
adult (2) 2
enoxaparin (2) 2
medicine, general & internal (2) 2
prognosis (2) 2
risk (2) 2
risk factors (2) 2
thromboembolism (2) 2
thrombolysis (2) 2
thrombosis (2) 2
unstable angina (2) 2
3rd-generation (1) 1
52fe (1) 1
59fe (1) 1
abo incompatibility (1) 1
acetylcholine (1) 1
activated (1) 1
activated factor vii (1) 1
activated factor x (1) 1
activatedprotein c (1) 1
activatedprotein c resistance (1) 1
acute (1) 1
acute lymphoblastic leukaemia (1) 1
acutemyeloid leukaemia (1) 1
acutemyelomonocytic leukaemia (1) 1
acutepromyelocytic leukaemia (1) 1
administration, oral (1) 1
adolescent (1) 1
adp receptors (1) 1
adultall (1) 1
adults (1) 1
adultt‐cell leukaemia (1) 1
adultt‐cell leukaemia/lymphoma (1) 1
age (1) 1
aiolos (1) 1
air travel (1) 1
algorithms (1) 1
all (1) 1
allogeneic (1) 1
allogeneicbone marrow transplantation (1) 1
allogeneichaematopoietic stem‐cell transplantation (1) 1
allogeneicstem cell transplantation (1) 1
alu‐associated homologous recombination (1) 1
amino‐terminal telopeptide of collagen type i (1) 1
aml (1) 1
anaemia (1) 1
analgesia (1) 1
androgens (1) 1
angiogenesis (1) 1
antibiotics (1) 1
anticoagulants - administration & dosage (1) 1
anticoagulants - therapeutic use (1) 1
antifactor viii antibody (1) 1
antiphospholipid antibodies (1) 1
antiphospholipid syndrome (1) 1
antisickling agents (1) 1
antithymocyte globulin (1) 1
anti‐phospholipid syndrome (1) 1
anti‐thymocyte globulin (1) 1
apc resistance (1) 1
aplastic anaemia (1) 1
apoptosis (1) 1
apoptotic apoptoticcells (1) 1
apoptoticgenes (1) 1
ataxia‐telangiectasia (1) 1
atra (1) 1
autoimmune (1) 1
autoimmune idiopathic thrombocytopenic purpura (1) 1
autoimmunelymphoproliferative syndrome (1) 1
autoimmunethrombocytopenic purpura (1) 1
autologous (1) 1
autologous stem cell transplantation (1) 1
autologoustransplantation (1) 1
b lymphocytes (1) 1
basophilic leukaemia (1) 1
bcl2 (1) 1
bcl6 (1) 1
bcr‐abl (1) 1
bcr‐abltranscript (1) 1
bernard–soulier syndrome (1) 1
beta2‐glycoprotein i (1) 1
beta‐2 glycoprotein 1 (1) 1
beta‐2‐glycoprotein i (1) 1
bfgf (1) 1
biological phenomena, cell phenomena, and immunity (1) 1
biomarkers - metabolism (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Konstantinides, Stavros V and Torbicki, Adam and Agnelli, Giancarlo and Danchin, Nicolas and Fitzmaurice, David and Galiè, Nazzareno and Gibbs, J. Simon R and Huisman, Menno V and Humbert, Marc and Kucher, Nils and Lang, Irene and Lankeit, Mareike and Lekakis, John and Maack, Christoph and Mayer, Eckhard and Meneveau, Nicolas and Perrier, Arnaud and Pruszczyk, Piotr and Rasmussen, Lars H and Schindler, Thomas H and Svitil, Pavel and Noordegraaf, Anton Vonk and Zamorano, Jose Luis and Zompatori, Maurizio and Achenbach, Stephan and Baumgartner, Helmut and Bax, Jeroen J and Bueno, Hector and Dean, Veronica and Deaton, Christi and Erol, Çetin and Fagard, Robert and Ferrari, Roberto and Hasdai, David and Hoes, Arno and Kirchhof, Paulus and Knuuti, Juhani and Kolh, Philippe and Lancellotti, Patrizio and Linhart, Ales and Nihoyannopoulos, Petros and Piepoli, Massimo F and Ponikowski, Piotr and Sirnes, Per Anton and Tamargo, Juan Luis and Tendera, Michal and Wijns, William and Windecker, Stephan and Jimenez, David and Ageno, Walter and Agewall, Stefan and Asteggiano, Riccardo and Bauersachs, Rupert and Becattini, Cecilia and Bounameaux, Henri and Büller, Harry R and Davos, Constantinos H and Geersing, Geert-Jan and Sanchez, Miguel Angel Gómez and Hendriks, Jeroen and Kilickap, Mustafa and Mareev, Viacheslav and Monreal, Manuel and Morais, Joao and Popescu, Bogdan A and Sanchez, Olivier and Spyropoulos, Alex C and Skoro-Sajer, N and Najafov, R and Sudzhaeva, S and De Pauw, M and Baraković, F and Tokmakova, M and Skoric, B and Rokyta, R and Hansen, M.L and Elmet, M and Harjola, V.P and Meyer, G and Chukhrukidze, A and Rosenkranz, S and Androulakis, A and Forster, T and Fedele, F and Sooronbaev, T and Maca, A and Ereminiene, E and Micallef, J and Andreasen, A and Kurzyna, M and Ferreira, D and Petris, A.O and Dzemeshkevich, S and Asanin, M and Simkova, I and Anguita, M and Christersson, C and Kostova, N and Baccar, H and Sade, L.E and ... and Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) and ESC Committee for Practice Guidelines (CPG) and Authors/Task Force Members and Document Reviewers
European Heart Journal, ISSN 0195-668X, 07/2014, Volume 35, Issue 43, pp. 3033 - 3080
Journal Article
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, ISSN 1469-493X, 2017, Issue 8
Journal Article
Anales de Pediatria, ISSN 1695-4033, 03/2015, Volume 82, Issue 3, pp. 144 - 151
Introduction Although critically ill children may be at risk from developing deep venous thrombosis (DVT), data on its incidence and effectiveness of... 
Pediatric intensivecare unit | Pediatrics | Anticoagulation | Heparin | Deep venousthrombosis
Journal Article
Pediatric Nephrology, ISSN 0931-041X, 06/2011, Volume 26, Issue 6, pp. 979 - 985
Journal Article
Российский кардиологический журнал, ISSN 1560-4071, 08/2015, Issue 8, pp. 67 - 110
The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)Endorsed by the European Respiratory... 
Pulmonary embolism | Venousthrombosis | Shock | Heart failure | Treatment– Anticoagulation | Dyspnoea | Chest pain | Diagnosis | Hypotension | Guidelines
Journal Article
Angiologia, ISSN 0003-3170, 09/2015, Volume 67, Issue 5, pp. 399 - 408
Thromboembolic venous disease (TVE) is a significant public health problem. The Primary Care physician (PCP) is an important figure in the prophylaxis,... 
Pulmonary embolus | Deep venousthrombosis | Venous thromboembolic disease | Prophylaxis | Anticoagulation | Post-thromboticsyndrome | Heparin | New oralanticoagulants
Journal Article
British Journal of Haematology, ISSN 0007-1048, 03/2003, Volume 120, Issue 6, pp. 1100 - 1103
androgens | ABO incompatibility | graft‐versus ‐plasma cell effect | telomere | Z deficiency | t(14;18) | acutemyeloid leukaemia | α‐thalassaemia | childhoodAPL | plateletshape change | T‐cell lymphoma | UMPH deficiency | karyotype | prognosticmodel | stomatocytosis | cyclophosphamide | eosinophilia | cobalamin deficiency | doxorubicin | Factor VIIa | leukaemogenesis | Burkitt'slymphoma | antifactor VIII antibody | 52Fe | PML/RARα | non‐homologous recombination | endocytic vesiculation | cardiolipin | bFGF | Aiolos | autoimmunethrombocytopenic purpura | irondeficiencyanaemia | chelation | proteinS | monoclonal gammopathy ofunknown significance | CD2 expression | acute lymphoblastic leukaemia | CD45isoforms | drug resistance | NUP98 | adult | childhoodcancer | treatment | plasmaexchange | recombinant | multicentric Castleman's disease | myelomaanimal model | NF‐κB inhibitor | venous | myeloma | haemostasis | bloodsubstitutes | enoxaparin | autoimmune idiopathic thrombocytopenic purpura | point mutation | fluorescence in situ hybridization | catheter‐relatedthrombosis | long haul flights | TCR‐γ | vasculitis | cytotoxic CD8 | TCR‐β | sex | blood | congenital bleeding disorder | bone marrow | skin rash | idiopathic myelofibrosis | MALT lymphoma | genetichaemochromatosis | autologous | monoclonal gammopathy ofundetermined significance | severe | solubleurokinase‐type plasminogen activator  receptor (suPAR) | translocation4;14 | resorption | clinical features | beta2‐glycoprotein I | gemcitabine | plasma | long‐term follow‐up | real‐time quantitativereverse‐transcription polymerase chain reaction | Danny Thomas | immunohaematological reconstitution | ironpolymaltose | screening | type 2M VWF | polycythaemia vera | T‐cellreceptor | autologous stem cell transplantation | immunosuppressive drugs | APC resistance | bonedensity | IL‐8/CXCL8 | aplastic anaemia | l‐arginine | sialoadhesin | thalidomide | chromosome 13 | recombinant ADAMTS13 | childhoodAML | protein C | autoimmune | STI571 | factorVII | chromosomes | Rituximab | primary progressive | soluble | RTK class III | Ikaros | guideline | transplantation | acutepromyelocytic leukaemia | economy class syndrome | P‐selectin | ferritin | Meningococcal sepsis | methionine synthase | ADP receptors | standardization | training | allogeneicstem cell transplantation | HOXD11 | RT‐PCR | fibrinogen Aα chain | prognosticindicators | Giovanni Di Guglielmo | integrin beta‐1 | β2m‐free HLA class I heavy chain | HHV‐8‐encoded viral homologues of cellular genes | human | bone marrowtransplantation | bcr‐abltranscript | haemochromatosis | translocation | graft‐versus ‐host disease | lymphoma | breast cancer | Gleevec | stroke | real‐time quantitative | FLT3 internal tandem duplication | idiotype | p38 MAP kinase | management | treatment‐related toxicity | PEL | synthase | iron | platelet | cancer | age | killing inhibitory receptor | factor IX gene | monocytic leukaemia zinc finger protein‐related factor gene | transferrinsaturation | C282Y mutation | CLL | in vivo imaging | perforin | bleeding | sickle | therapy‐relatedmyelodysplastic syndrome | B lymphocytes | transferrin | CD40/CD40L | stem celltransplantation | chemotherapy | fluorescencemicroscopy | severe aplastic anaemia | reactive T cells | SLL | normalization | stemcells | hairy cell leukaemia | spectratype | guidelines | activatedprotein C | CMK | granulocyte colony‐stimulating factorreceptor | osteolytic bone destructions | CML | angiogenesis | activated factor VII | polycythaemia veramanagement | quantitative real‐time PCR | antiphospholipid antibodies | deferiprone | mutation | haplotypes | hypogonadism | megakaryoblastic cell line | HS‐40 | obligate heterozygotes | tumourantigen | leukaemia | Hodgkin's disease | T‐LGL | real‐time quantitativereverse transcription polymerase chain reaction (PCR) | imatinib mesylate | basophilic leukaemia | dysfunction | myelodysplasia | haemolytic anaemia | SCID mouse | sicklecell disease | tumour | venousthromboembolism | Ca2+ ionophore | c‐fms | haemophilia | blood stem cells | transplant | outcome | lipopolysaccharide (LPS) | plateletglycoprotein Ib | orthopaedic surgery | leucocytes | high‐dose therapy | interleukin 2 2 (IL‐2) | hydroxyurea | BCL6 | plateletsize heterogeneity | lymphoproliferativedisorder | BCL2 | hypercoagulable state | granulocyte‐macrophage colony stimulating factor (GM‐CSF) | rhodamine | Donald Pinkel | ALL | granzyme B | FLT3 | adultALL | polymorphism | transfusion | immunocompromised | LSP1 | non‐Hodgkin's lymphoma | amino‐terminal telopeptide of collagen type I | dendritic cell (DC) | mast cells | CD11c | E‐cadherin | t(1;19) translocation | imatinib mesylate (Glivec, Gleevec) | paediatrics | haematological malignancies | mutations | OHK | fluorescence | von Willebranddisease | T‐LGLleukaemia | NOD/SCID mice | puberty | erythropoiesis | single nucleotide polymorphisms | chronic | desmopressin | haemoglobin ‐based oxygen carrier Hemolink | AML | peripheral | multiple myeloma | endogenouserythroid colony growth | signal transduction | therapy‐related | beta‐2 glycoprotein 1 | diagnosis | Cos‐7 cells | t(2;11)(q31;p15) | VWF‐cleaving protease | acutemyelomonocytic leukaemia | clinical | lead poisoning | methylenetetrahydrofolate reductase | target antigens | erythroblasts | unstable angina | ATRA | paroxysmal nocturnal haemoglobinuria | E2A–PBX1 | intracellular Ca2 | chemokine | differentiation | GVHD prophylaxis | PRCA | elderly | leucocyte | anticoagulation | apoptosis | HLA molecules | Burkitt‐like | GATA‐1 | von Willebrand | Di Guglielmo's syndrome | triathlon | TTP | oxidative burst | telomerase | Bernard–Soulier syndrome | leucopenia | nitric oxidemetabolites | cisplatin | N‐glycosylation | erythropoietin | endothelium | p‐glycoprotein | proteindegradation | follicular lymphoma | sports | CNS infiltration | DDAVP | miscarriage | air travel | control | acutemyeloid leukaemia (AML) | myeloidproliferative disease | first remission | prothrombin deficiency | Beta‐2‐glycoprotein I | NK cell | Fanconi's anaemia | mu class isoforms | ataxia‐telangiectasia | CTL | irondepletion | autoimmunelymphoproliferative syndrome | activated | haemophiliaB | megaloblastic anaemia | myeloproliferativedisorders | photosensitivity | ironoverload | PNH | cytogenetics | M3 variant | ischaemic stroke | Japanese cord blood bank network | twin study | pregnancycomplications | catheter‐related | protein | glutathione S‐transferases | homing | monoclonal gammopathy of uncertain significance | bloodmononuclear cells | cord blood transplantation | tamoxifen | Helios | short isoform | peptide | relapse | pregnancy | molecular response | prognostic factor | platelets | LGL | vaso‐occlusive crisis | lymph nodes | t(3;14) | erythema nodosum | pyruvate kinase deficiency | stem cell collection | plateletactivation and function | dendritic cell | essential thrombocythaemia | lymphoproliferative disease of granular lymphocytes | CD20 | endogenous | immune deficiency | refractory anaemia | Fcγ receptors | haemolytic | cell activation | chest crisis | irondeficiency | genetic associations | recombinantprotein | imatinib mesylate(Glivec | TCR/CD3 protein | diversity | dendritic celldepigmentation | vinblastine | allogeneic | haematological malignancy | mantle cell lymphoma | monoclonal gammopathy of | MTFHR MTHFR | severecongenital neutropenia | prognosticfeatures | genetic | CD30 | adultT‐cell leukaemia | childhood | complications | trisomy 21 | prognosis | haematopoiesis | cation leak | catheter‐related infection | erythrocytosis | desferrioxamine | haemoglobinraffimer | t(11;18) | immunoglobulin variable region genes | FISH | dysprothrombinaemia | myelodysplastic syndrome | somatic mutation | standard therapy | centralnervous system relapse | pharmacokinetic study | transient leukaemia | T‐celllarge granular lymphocyte leukaemia | tissue factor | centralvenous catheter | brachydactyly type C | haematopoietic | CD27–CD70 interaction | CD38 | antisickling agents | 59Fe | CD35 | CD34 | chroniclymphocytic leukaemia | IL‐4 | antithymocyte globulin | endogenousthrombin potential | neutropenia | haemolyticuraemic syndrome | NOS inhibitor | chronicmyeloid leukaemia (CML) | nucleotidase | IL‐15 | systemic mast cell disease | genotype | folate | T‐prolymphocytic leukaemia (T‐PLL) | serine/threonine phosphorylation | hypoprothrombinaemia | TNF‐α transcription | instability | cardiolipinbinding | plateletfunction | haematopoietic cell transplantation | CD45 | CD43 | DNA sequencing | gestational thrombotic miroangiopathic anaemia | α‐globin gene | clopidogrel | chronic graft‐versus‐host disease | clinicalmanagement | T‐cellacute lymphoblastic leukaemia (T‐ALL) | haematopoieticstem cell transplantation | adults | T‐cell | thrombus precursor protein | modified CHOP chemotherapy | gag | cutaneous T‐cell lymphoma (CTCL) | therapy‐related acute myeloid leukaemia/myelodysplasia | epidemiology | minimal | central | thrombosis | CXCR1 | BNLI | CD59 | cytopenia | factor | isotype switching | MTHFRC677T | PFA‐100 | harvest | pain | risk factor | bonepain | P5 N deficiency | high‐grade transformation | genotypes | SLVL | bone | p15 methylation | polymorphisms | parvovirus B19 | neurological dysfunction | flt3‐ligand | G‐CSF | deep vein thrombosis | deficiency | haemolysis | T‐ALL | immunophenotype | myeloproliferative | tumournecrosis factor‐alpha (TNF‐α) | morphological dysplasia | MIP‐1α | risk | cell–cell interaction | extramedullary relapse | mean platelet volume | CD86 | minimalresidual disease (MRD) | Philadelphia‐chromosome‐positive acute lymphoblastic leukaemia | CD80 | HFE | analgesia | anti‐thymocyte globulin | graft‐versus ‐leukaemia effect | adultT‐cell leukaemia/lymphoma | p53 | paediatric | humanherpesvirus 6 | large‐volume leukapheresis | haemoglobin | high‐risk febrile neutropenia | myeloid leukaemia | children | deletion | menstruation | manganese superoxide dismutase | cytokines | flow cytometry | splenectomy | PDGFRB | nitric oxide | quantification | anti‐phospholipid syndrome (APS) | gene | FLT3/ITD | glycosylation | soluble HLA‐I | ultrastructure | recombinantVIIa | peak bone mass | co‐stimulatory molecules | tandem transplants | non‐myeloablative | low‐risk febrile neutropenia | thrombin generation | antibiotics | telomeremetabolism | CD88 | CD87 | Factor VII/VIIa | infection | minimalconditioning | TIA‐1 | erythrocytes | proteasome inhibitor | unrelated donor | T‐cellimmunophenotype | chronicmyeloid leukaemia | apoptotic apoptoticcells | carboxy‐terminal telopeptide of collagen type I | apoptoticgenes | gemtuzumab ozogamicin | chronicmyelogenous leukaemia | translocation(10;16) | pyridinolines | HS‐33α major regulatory element | managementguidelines | HIV | phagocyte activation | sicklecell anaemia | factor XIII | regimen‐related toxicity | statistical analysis | Alu‐associated homologous recombination | FGFR3 | mesenchymal cells | venousthrombosis | Burkitt's | childhoodITP | red cell utilization | positron emission tomography (PET) | bone marrowmicroenvironment | Siva | myocardial infarction | gene expression | microangiopathic haemolytic anaemia | innate immunity | menopause | interleukin 2 | genetransfer | activatedprotein C(APC) resistance | conditioning regimens | cone and plate(let) analyser | crisis | graft‐versus ‐lymphoma effect | hyaluronan | survival | CREB binding protein gene | blood coagulation | c‐kit | prognostic | CD45 (LCA) | thrombophilia | myeloproliferative disorder | complete remission | fludarabine | von Willebrandfactor | neuropathy | malignant lymphoma | acute | bcr‐abl | GPIb | pathology | thalassaemia | thrombocytopenia | allogeneichaematopoietic stem‐cell transplantation | idiotypevaccination | case report | INR | TFPI | β‐thalassaemia | Hashimoto's thyroiditis | low leucocyte count | integrins | MUC1 | respiratory symptoms | autologoustransplantation | GPI anchor | Helicobacter pylori | myeloid | plateletperoxidase | stem cell | immunotherapy | allogeneicbone marrow transplantation | glucocorticoids | immunohistochemistry | plasma cell purification | tyrosine phosphorylation | interleukin | α thalassaemia | peripheral blood mononuclear cells | HHV‐6 | bonelesions | ζ chain | anaemia | interleukin8 | endothelial cell | riskfactors | human herpesvirus‐8 | lymphoproliferative | myeloperoxidase | thrombotic thrombocytopenic purpura | intracranial haemorrhage | MEGO1 | extra‐gastric | erythroleukaemia | granulocyte colony‐stimulating factor | high‐resolution computerized tomography | investigation | leukaemic pulmonary infiltrates | SCL
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.